Evidence map›Paper›PMID 32641446›Full record

GuidelineStroke and vascular neurology2020

Expert consensus on prevention and control of COVID-19 in the neurological intensive care unit (first edition).

Furong Wang, Jingyi Liu, Ping Zhang, Wen Jiang, Le Zhang, Meng Zhang, Junfang Teng, Jinquan Wang, Xiaoqi Xie, Jie Cao and 6 more

Abstract readPractice GuidelineConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Guideline in Stroke and vascular neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Furong WangDepartment of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.ORCID 0000-0001-8693-7301
Jingyi LiuDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.ORCID 0000-0001-7360-0267
Ping ZhangDepartment of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wen JiangDepartment of Neurology, Xijing Hospital, Air Force Medical University, Xi'an, China.ORCID 0000-0002-2000-6640
Le ZhangDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, China.
Meng ZhangDepartment of Neurology, Third Military Medical University Daping Hospital and Research Institute of Surgery, Chongqing, China.
Junfang TengDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Jinquan WangDepartment of Intensive Care Unit, The First Affiliated Hospital of University of Science and Technology of China, Hefei, China.
Xiaoqi XieDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
Jie CaoDepartment of Neurology, The First Hospital of Jilin University, Changchun, China.
Wei LiDepartment of Neurology, Third Military Medical University Daping Hospital and Research Institute of Surgery, Chongqing, China.
Yongming WuDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Hao ZhouDepartment of Infectious Management, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Yingying SuDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China lipingsister@gmail.com pansuyue@smu.edu.cn tangsuyingying@sina.com.
Suyue PanDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China lipingsister@gmail.com pansuyue@smu.edu.cn tangsuyingying@sina.com.
Liping LiuDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China lipingsister@gmail.com pansuyue@smu.edu.cn tangsuyingying@sina.com.ORCID 0000-0003-2943-055X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the COVID-19 epidemic, the treatment of critically ill patients has been increasingly difficult and challenging. During the epidemic, some patients with neurological diseases also have COVID-19, which could be misdiagnosed and cause silent transmission and nosocomial infection. Such risk is high in a neurological intensive care unit (NCU). Therefore, prevention and control of epidemic in critically ill patients is of utmost importance. The principle of NCU care should include comprehensive screening and risk assessment, weighing risk against benefits and reducing the risk of COVID-19 transmission while treating patients as promptly as possible.

Indexed as

BetacoronavirusConsensusCoronavirus InfectionsCOVID-19Critical IllnessCross InfectionHost-Pathogen InteractionsHumansInfection ControlInfectious Disease Transmission, Patient-to-ProfessionalIntensive Care UnitsNervous System DiseasesNeurologyOccupational HealthPandemicsPatient Safetyinfection

Identifiers

PMID32641446
PMCPMC7548511

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.